首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1481941

到 2030 年北美魚疫苗市場預測 - 區域分析 - 按疫苗類型、應用、給藥途徑和物種

North America Fish Vaccines Market Forecast to 2030 - Regional Analysis - by Vaccine Type, Application, Route of Administration, and Species

出版日期: 2024年02月28日 | 出版商:

The Insight Partners | 英文 79 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年北美魚疫苗市場估值為1.6022億美元，預計2030年將達到2.6807億美元；預計2022年至2030年複合年成長率為6.6%。

政府發展水產養殖業的措施推動北美魚疫苗市場

由於對海鮮的高需求和野生魚類年捕撈量的減少，水產養殖呈指數級成長。因此，各國政府正採取措施改善和支持水產養殖業的發展。以下是最近的一些舉措：

2021 年 2 月，食品與農業研究基金會 (FFAR) 資助 790,326 美元創建疫苗輸送系統，幫助阻止羅非魚湖病毒和其他疾病在水產養殖領域的傳播。

Sea Grant 海洋水產養殖補助計劃：這項全國性的競爭性補助計劃，正式名稱為“國家海洋水產養殖計劃 (NMAI)”，旨在促進研究和示範計劃，以推動美國永續海水養殖。

NOAA 小型企業創新研究 (SBIR) 計畫：NOAA 的 SBIR 計畫促進小型企業利用聯邦資金投資尖端技術以及可實現商業化的下一代產品和流程，支持對水產養殖研究和開發的投資。

其他一些計劃包括 NOAA 漁業融資計劃、海洋漁業計劃 (MARFIN) 和其他區域試點項目。

2022 年，美國農業部國家食品和農業研究所 (NIFA) 宣布投資超過 1,300 萬美元，用於研究動物疾病的新療法和預防措施，這些疾病給全球農業部門帶來了數十億美元的損失。其中包括向密西西比州立大學撥款 625,000 美元，用於評估一種抗菌飼料添加劑，該添加劑可用於以安全有效的方式預防鯰魚腸敗血症。這項研究將有助於開發水產養殖生產者的處理替代方案，並提高生產效率。

因此，政府支持水產養殖業發展的舉措的增加推動了魚疫苗市場的成長。

北美魚疫苗市場概況

北美魚疫苗市場分為美國、加拿大和墨西哥。該地區的市場成長歸因於水產養殖業的成長和對水生動物性食品的需求激增。據美國國家海洋和大氣管理局稱，美國水產養殖每年創收約 15 億美元。根據世界銀行的數據，美國生產了約 44.8 萬噸水產養殖產品。據同一來源稱，2021 年北美產量約 560 萬尾，其中美國產量約 470 萬尾，約佔該地區魚類總產量的 83%。因此，美國水產養殖產量的增加正在推動魚疫苗市場的成長。

北美魚疫苗市場收入及 2030 年預測（百萬美元）

北美魚疫苗市場區隔

北美魚疫苗市場根據疫苗類型、應用、給藥途徑、物種和國家進行細分。

依疫苗類型，北美魚苗市場分為去活化疫苗、減毒活疫苗、次單位疫苗、重組載體疫苗等。 2022 年，去活化疫苗細分市場佔據最大市場佔有率。

根據應用，北美魚疫苗市場分為細菌感染、病毒感染和寄生蟲。 2022 年，細菌感染細分市場佔最大市場。

根據給藥途徑，北美魚苗市場分為注射疫苗、浸沒疫苗和口服疫苗。 2022年，注射疫苗細分市場佔據最大市場佔有率。

根據物種，北美魚疫苗市場分為鮭魚、鱒魚、羅非魚等。 2022 年，鮭魚細分市場佔據最大的市場。

按國家/地區分類，北美魚疫苗市場分為美國、加拿大和墨西哥。 2022年，美國在北美魚疫苗市場佔有率中佔據主導地位。

Elanco Animal Health Inc.、Hipra SA、Merck & Co Inc.、Phibro Animal Health Corp、Vaxxinova International BV 和 Zoetis Inc. 是北美魚疫苗市場上的一些領先公司。

NOAA Small Business Innovation Research (SBIR) Program: NOAA's SBIR program, which promotes small firms to use federal funds to invest in cutting-edge technologies and next-generation products and processes that can lead to commercialization, supports investments in aquaculture research and development.

Some other programs include the NOAA Fisheries Finance Program, Marine Fisheries Initiative (MARFIN), and other regional pilot projects.

In 2022, the USDA National Institute of Food and Agriculture (NIFA) announced a research investment of more than US$ 13 million to investigate new treatments and preventative measures for animal illnesses that cost the global agriculture sector billions of dollars. This included a US$ 625,000 grant to Mississippi State University to assess an antibacterial feed additive that can be used to prevent enteric septicemia in catfish in a secure and useful manner. This study will contribute to developing aquaculture producers' treatment alternatives, improving production efficiency.

Thus, an increase in government initiatives to support developments in the aquaculture industry drives the fish vaccine market growth.

North America Fish Vaccines Market Overview

The North America fish vaccines market is segmented into the US, Canada, and Mexico. The market growth in this region is attributed due to the growing aquaculture industry and surging demand for aquatic animal-derived food products. According to the National Oceanic and Atmospheric Administration, aquaculture generate ~US$ 1.5 billion annually in the US. According to the World Bank, the US produced ~448 thousand metric tons aquacultural products. As per the same source, about 5.6 million fish were produced in 2021 in North America, of which ~4.7 million is produced in the US, which is ~83% of the total region fish production. Thus, the increase in aquaculture production in the US is fueling the growth of the fish vaccines market.

North America Fish Vaccines Market Revenue and Forecast to 2030 (US$ Million)

North America Fish Vaccines Market Segmentation

The North America fish vaccines market is segmented based on vaccine type, application, route of administration, species, and country.

Based on vaccine type, the North America fish vaccines market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest market share in 2022.

Based on application, the North America fish vaccines market is segmented into bacterial infection, viral infection, and parasitic. The bacterial infection segment held the largest market share in 2022.

Based on route of administration, the North America fish vaccines market is segmented into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held the largest market share in 2022.

Based on species, the North America fish vaccines market is segmented into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022.

Based on country, the North America fish vaccines market is segmented into the US, Canada, and Mexico. The US dominated the North America fish vaccines market share in 2022.

Elanco Animal Health Inc, Hipra SA, Merck & Co Inc., Phibro Animal Health Corp, Vaxxinova International BV, and Zoetis Inc. are some of the leading companies operating in the North America fish vaccines market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 North America Fish Vaccine Market

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Fish Vaccine Market - Key Industry Dynamics

4.1 Market Drivers:
- 4.1.1 Government Initiatives to Develop Aquaculture Industry
- 4.1.2 Surging Demand for Aquatic Animal-Derived Food Products
4.2 Market Restraints
- 4.2.1 Stringent Regulations for Approval of Vaccine
4.3 Market Opportunities
- 4.3.1 Development of Novel Fish Vaccine
4.4 Future Trends
- 4.4.1 Technological Advancements in Fish Vaccine
4.5 Impact Analysis:

5. Fish Vaccine Market - North America Market Analysis

5.1 Fish Vaccine Market Revenue (US$ Th), 2022 - 2030

6. North America Fish Vaccine Market - Revenue and Forecast to 2030 - by Vaccine Type

6.1 Overview
6.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
6.3 Inactivated Vaccines
- 6.3.1 Overview
- 6.3.2 Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
6.4 Live Attenuated Vaccines
- 6.4.1 Overview
- 6.4.2 Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
6.5 Subunit Vaccines
- 6.5.1 Overview
- 6.5.2 Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
6.6 Recombinant Vector Vaccine
- 6.6.1 Overview
- 6.6.2 Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

7. North America Fish Vaccine Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
7.3 Bacterial Infection
- 7.3.1 Overview
- 7.3.2 Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
7.4 Viral Infection
- 7.4.1 Overview
- 7.4.2 Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
7.5 Parasitic
- 7.5.1 Overview
- 7.5.2 Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

8. North America Fish Vaccine Market - Revenue and Forecast to 2030 - by Route of Administration

8.1 Overview
8.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
8.3 Injection vaccine
- 8.3.1 Overview
- 8.3.2 Injection vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
8.4 Immersion Vaccine
- 8.4.1 Overview
- 8.4.2 Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
8.5 Oral Vaccine
- 8.5.1 Overview
- 8.5.2 Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

9. North America Fish Vaccine Market - Revenue and Forecast to 2030 - by Species

9.1 Overview
9.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
9.3 Salmon
- 9.3.1 Overview
- 9.3.2 Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
9.4 Trout
- 9.4.1 Overview
- 9.4.2 Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
9.5 Tilapia
- 9.5.1 Overview
- 9.5.2 Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

10. North America Fish Vaccine Market - Country Analysis

10.1 North America Fish Vaccine Market, Revenue and Forecast To 2030
- 10.1.1 Overview
- 10.1.2 North America Fish Vaccine Market, by Country
  - 10.1.2.1 US
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 US Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
    - 10.1.2.1.3 US: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
    - 10.1.2.1.4 US: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
    - 10.1.2.1.5 US: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
    - 10.1.2.1.6 US: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
  - 10.1.2.2 Canada
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 Canada Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
    - 10.1.2.2.3 Canada: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
    - 10.1.2.2.4 Canada: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
    - 10.1.2.2.5 Canada: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
    - 10.1.2.2.6 Canada: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
  - 10.1.2.3 Mexico
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 Mexico Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
    - 10.1.2.3.3 Mexico: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
    - 10.1.2.3.4 Mexico: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
    - 10.1.2.3.5 Mexico: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
    - 10.1.2.3.6 Mexico: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)

11. Fish Vaccine Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in Fish Vaccine Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Zoetis Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Merck & Co Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 HIPRA SA
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Phibro Animal Health Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Vaxxinova International BV
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Elanco Animal Health Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Fish Vaccine Market Segmentation
Table 2. Worldwide Fish Production and Consumption in 2022
Table 3. Major Bacterial Diseases in Fish
Table 4. Major Viral Diseases in Fish
Table 5. Major Parasitic Diseases in Fish
Table 6. Atlantic Salmon Production 2020
Table 7. US Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
Table 8. US Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
Table 9. US Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
Table 10. US Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
Table 11. Canada Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
Table 12. Canada Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
Table 13. Canada Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
Table 14. Canada Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
Table 15. Mexico Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
Table 16. Mexico Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
Table 17. Mexico Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
Table 18. Mexico Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
Table 19. Recent Inorganic Growth Strategies in the Fish Vaccine Market
Table 20. Recent Organic Growth Strategies in Fish Vaccine Market
Table 21. Glossary of Terms, Fish Vaccine Market

List Of Figures

Figure 1. North America Fish Vaccine Market Segmentation, By Country
Figure 2. North America Fish Vaccine Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Fish Vaccine Market Revenue (US$ Th), 2022 - 2030
Figure 5. North America Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
Figure 6. Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 7. Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 8. Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 9. Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 10. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 11. North America Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
Figure 12. Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 13. Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 14. Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 15. North America Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
Figure 16. Injected: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 17. Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 18. Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 19. Fish Vaccine Market Revenue Share, Species, 2022 & 2030 (%)
Figure 20. Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 21. Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 22. Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 23. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 24. North America: Fish Vaccine Market, by Key Country - Revenue (2022) (US$ Thousand)
Figure 25. North America Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
Figure 26. US Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 27. Canada Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 28. Mexico Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 29. Growth Strategies in Fish Vaccine Market